
Aloglip12.5 mg
Navana Pharmaceuticals Ltd.
Alogliptin Benzoate is a dipeptidyl peptidase-4 (DPP-4) inhibitor indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Alogliptin Benzoate is a dipeptidyl peptidase-4 (DPP-4) inhibitor indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Alogliptin Benzoate is not a substitute for insulin in patients who require insulin therapy and should not be used for weight loss or as a first-line agent in place of lifestyle modification.
| Indication / Renal Function | Recommended Dose of Alogliptin Benzoate |
|---|---|
| Standard dose (normal renal function or mild renal impairment, CrCl ≥ 60 mL/min) | 25 mg orally once daily |
| Moderate renal impairment (CrCl 30 to less than 60 mL/min) | 12.5 mg orally once daily |
| Severe renal impairment (CrCl less than 30 mL/min) or end-stage renal disease requiring dialysis | 6.25 mg orally once daily, without regard to timing of dialysis |
Safety and efficacy of Alogliptin Benzoate have not been established in pediatric patients under 18 years of age; therefore, no pediatric dosing recommendation exists.
No dose adjustment of Alogliptin Benzoate is required in mild to moderate hepatic impairment. Use in severe hepatic impairment is not recommended due to limited clinical data.
Most patients tolerate Alogliptin Benzoate well. Side effects are generally mild, but some can be serious and require prompt medical attention.
Alogliptin Benzoate is contraindicated in patients with:
Alogliptin Benzoate is not indicated for the treatment of type 1 diabetes mellitus or diabetic ketoacidosis; these are not indications requiring use of Alogliptin Benzoate.
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.